Longitudinal Analysis of Participants in The KEEP Mexico's Chronic Kidney Disease Screening Program
- 1 November 2013
- journal article
- research article
- Published by Elsevier BV in Archives of Medical Research
- Vol. 44 (8), 650-654
- https://doi.org/10.1016/j.arcmed.2013.10.006
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Establishing the Global Kidney Disease Prevention Network (KDPN): A Position Statement From the National Kidney FoundationAmerican Journal of Kidney Diseases, 2011
- Standards of Medical Care in Diabetes—2011Diabetes Care, 2011
- Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP USKidney International, 2010
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney DiseaseAmerican Journal of Kidney Diseases, 2007
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-AnalysisAnnals of Internal Medicine, 2003
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyThe New England Journal of Medicine, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998